Immuneering's Corporate Majority Round

Immuneering raised a round of funding on August 03, 2015. Investors include Teva Pharmaceuticals.

Immuneering helps pharmaceutical companies use genetic, genomic, and proteomic data to generate biological insights that enhance the clinical and commercial success of medicines.…

Articles about Immuneering's Corporate Majority Round: